|
Volumn 12, Issue 16, 2002, Pages 2153-2157
|
Rational design of 4,5-disubstituted-5,7-dihydro-pyrrolo[2,3-d]pyrimidin-6-ones as a novel class of inhibitors of epidermal growth factor receptor (EGF-R) and Her2(p185erbB) tyrosine kinases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
PHOSPHOTYROSINE;
PYRIMIDINONE DERIVATIVE;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
KETONE DERIVATIVE;
PROTEIN P185;
PROTEIN TYROSINE KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
METABOLISM;
PHOSPHORYLATION;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ANIMAL CELL;
AUTOPHOSPHORYLATION;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SELECTIVITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
FEMALE;
HUMAN;
HUMAN CELL;
MOUSE;
NONHUMAN;
ONCOGENE NEU;
PROTEIN FAMILY;
PROTEIN PHOSPHORYLATION;
DRUG DESIGN;
ENZYME INHIBITORS;
MOLECULAR STRUCTURE;
PHOSPHORYLATION;
PHOSPHOTYROSINE;
PYRIMIDINONES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0037136012
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00364-5 Document Type: Article |
Times cited : (27)
|
References (10)
|